Stay updated with breaking news from Clinical Practice Recommendations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Providers of innovative adaptive hunting and shooting products Digital FOV, LLC announces the approval of their Adaptive Rifle Scope Clip-on by the Veterans...
AstraZeneca and FibroGen, Inc. (FibroGen) today announced that the US Food and Drug Administration (FDA) informed FibroGen that it will convene a meeting of the Cardiovascular and Renal Drugs Advisory Committee to review the new drug application for roxadustat. Roxadustat is under regulatory review for the treatment of anaemia of chronic kidney disease (CKD). AstraZeneca and FibroGen are committed to working with the FDA ahead of the meeting and to bringing roxadustat to patients with anaemia of CKD. A date for the advisory committee meeting has not been determined. The efficacy and safety of...